Products > EBTATE

EBTATE

EBTATE incorporates Evans Blue (EB) in the somatostatin analog backbone which significantly increases residence in albumin, a virtual slow release system. Conjugating a targeting molecule to Evans Blue (EB =albumin-binding motif) prolongs half-life in blood, enhancing theranostic bioavailability. In a head-to-head comparison, long-acting EBTATE showed favorable in vivo pharmacokinetics and anti-tumor efficacy vs. TATE.

Nukleon Nükleer Teknoloji Araştırma San. ve Tic. Ltd. Şti
Çifte Havuzlar Mahallesi
Yıldız Teknik Üniversitesi Teknoloji Geliştirme Bölgesi
TEKNOPARK Arge-2 Davutpaşa
34220 Esenler/İstanbul
© Copyright 2021 Nukleon